This job has expired

You will need to login before you can apply for a job.

Business Development Internship

NextCure, Inc.
Beltsville, MD
Start date
Mar 11, 2023

Job Details

NextCure is a biopharmaceutical company located in Beltsville, MD, and focuses on the discovery and development of first-in-class biologic therapeutics for the treatment of cancer and other immune-related diseases.

We are seeking a highly motivated and dedicated Intern to perform business and competitive intelligence analyses, communicate results to leadership team, and organize information in databases. The role requires high energy, an enthusiastic individual with an ambitious personality, and a strong desire to achieve and to learn about the biotechnology industry. The ideal candidate should work with a sense of urgency and constantly adapt to changing environments. This is a great opportunity for a PhD scientist or a recent MBA graduate with a desire to pursue a career in business and corporate development functions in the biotechnology industry and who is seeking to acquire the relevant skills.

As a Business Development Intern, subject to the NextCure Intern Agreement, the primary duties of the internship will include:

  • Conducting business and competitive intelligence analyses on innovative technologies and therapeutic candidates using relevant scientific and clinical publications and patents
  • Perform landscape analyses to identify business leads in specific therapeutic areas
  • Scout licensing opportunities and evaluate business rationale that align with company’s interests
  • Generate reports and presentations summarizing data and information into clear messages for communication to leadership team
  • Build and maintain a database to organize information analyzed

Required education and candidate profile

  • PhD in life science with interest in business development or MBA student with an academic background in the life sciences or medicine and business management.
  • Basic understanding of biotechnology and pharma industries
  • Quick learner with excellent communication skills

This internship is currently set for 6 months however, an extension may be considered. This is a part-time (30 hr/week) internship that will be compensated.

NextCure is an Equal Opportunity Employer and offers a competitive salary and benefits package in a scientifically engaged team work environment.


NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

Cancer is a complex disease where cells in the tumor microenvironment promote tumor progression, immune evasion and suppression of anti-tumor immune responses. While therapies targeting inhibitory or immune checkpoint molecules have shown important success in many cancers, not all patients benefit from these therapies (non-responders), and many develop resistance after initial treatment. NextCure is identifying novel tumor-specific interactions and mechanisms of immune regulation to generate a sustainable product pipeline to address these patients in need.

NextCure brings significant experience and innovation in cancer immunology. The company’s FIND-IOTM technology provides a large repertoire of function-based screens and imparts a unique understanding of cell surface molecular interactions between immune and diseased cells. We are using this important knowledge to rapidly develop and advance novel biologics that impact suppressive myeloid cell populations, T cell subsets, and other cell populations within the tumor microenvironment to restore anti-tumor activity and improve clinical response rates and outcomes for patients.

Stock Symbol: NXTC

Find Us
9000 Virginia Manor Rd. Suite 200

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert